Work

GYKI 52466, a 2,3-benzodiazepine, is a highly selective, noncompetitive antagonist of AMPA/kainate receptor responses

Year: 1993

Type: article

Source: Neuron

DOI: 10.1016/0896-6273(93)90241-i

Authors: Sean D. Donevan, Michael A. Rogawski

Institutions: National Institutes of Health, National Institute of Neurological Disorders and Stroke

Language: English

Topic: Neuroscience and Neuropharmacology Research

Subfield: Cellular and Molecular Neuroscience

Field: Neuroscience

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2091837097

FWCI: 9.025

Cites: 41

Cited by: 359

Related to: 10